Identification of MAD2L1 as a Potential Biomarker in Hepatocellular Carcinoma via Comprehensive Bioinformatics Analysis

Figure 6

High expression of MAD2L1 in HCC: (a) the expression levels of MAD2L1 were analyzed by qRT-PCR in HCC cells and normal hepatocytes; (b) The expression levels of MAD2L1 were analyzed by western blot in HCC cells and normal hepatocytes; (c) MAD2L1 expression in tumors and adjacent samples was detected by IHC on tissue arrays (scale bar: 50 μm); (d) expression of MAD2L1 was scored by IHC on tissue arrays in tumor and adjacent samples; (e) Kaplan-Meier survival analysis for disease-free survival; (f) Kaplan-Meier survival analysis for disease-free survival.

(a)

(b)

(c)

(d)

(e)

(f)